Tech Company Financing Transactions
Profluent Funding Round
On 4/28/2026, Profluent raised investment from Eli Lilly and Company.
Transaction Overview
Company Name
Announced On
4/28/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
This collaboration with Lilly demonstrates that our platform is ready to build the toolkit needed to scale genetic medicines. We're seeing strong demand from the pharmaceutical industry, and this partnership validates our approach to solving previously intractable problems.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2630 Bancroft Way
Berkeley, CA 94704
USA
Berkeley, CA 94704
USA
Phone
Undisclosed
Website
Email Address
Overview
Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ali Madani
Vice President
Peter Cameron
VP - Bus. Development
Hilary Eaton
Browse more venture capital transactions:
Prev: 4/28/2026: Cnuic Technologies venture capital transaction
Next: 4/28/2026: CleanDesign venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs